Snowball logo
logo
  • Stocks
  • China
  • Healthcare
3005

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

300534 • SHE
¥18.92¥0.00  (0%)
Estimate
P/E
118.3
EPS
0.16
Beta
0.449
Growth
Revenue, YoY
-19.99%
Net income, YoY
1.86%
FCF, YoY
85.35%
Dividends
Dividend yield
0.21%
Annual payout
¥0.04
Next ex. div date
November 22, 26
Payout
11.06%
Div.growth, 5y
31.95%
Div.rating
About the company
Ticker
300534
ISIN
CNE100002CP5
Country
China
Sector (GICS)
Healthcare
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

Frequently asked questions

What sector does Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) operate in?

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) current stock price?

As of the latest data, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd stock price is CN¥18.92, with a previous close of CN¥18.92.

What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) current market capitalization?

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd market cap is approximately 5.74 billion.

What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.16.

What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) Price-to-Earnings (P/E) ratio?

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd current P/E ratio is 118.25.

Does Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) pay dividends?

Yes. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd pays semiannual dividends with an annualized yield of 0.21% and an estimated annual payout of CN¥0.04 per share.

When is the next ex-dividend date for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534)?

The next ex-dividend date is scheduled for November 22, 2026.

What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) beta (volatility) score?

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd has a beta of 0.449, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.